Rationale and Design of an Artificial Intelligence Model for Diastolic Heart Failure (AID-HF): A Canadian Cardiomyopathy Collaborative (C3) Study
Authors:
- Tanya PapazTPTanya Papaz
- Suhani PatelSPSuhani Patel
- Rajadurai AkilenRARajadurai Akilen
- Sandar MinSMSandar Min
- Robert LesurfRLRobert Lesurf
- Matthieu RuizMRMatthieu Ruiz
- Christopher Z LamCLChristopher Z Lam
- Andreea DragulescuADAndreea Dragulescu
- Mark K FriedbergMFMark K Friedberg
- Luc MertensLMLuc Mertens
- Maxime Tremblay-GravelMTMaxime Tremblay-Gravel
Preprint
Abstract
Diastolic heart failure (HF) in primary cardiomyopathy is under-recognized and often diagnosed late, particularly in children. While recent studies have advanced understanding of HF with preserved ejection fraction in older adults, the prevalence, outcomes and molecular drivers of diastolic HF in pediatric and young adult cardiomyopathy remain poorly defined, where disease is typically driven by primary myocardial disease rather than acquired co-morbidities. The Canadian Cardiomyopathy Collaborative (C3) was assembled to leverage three of Canada’s leading pediatric and adult cardiomyopathy biobank registries. Its flagship initiative, Artificial Intelligence to Model Diastolic Heart Failure (AID-HF), aims to integrate deep phenotyping - including comprehensive diastolic function assessment - with genomics, lipidomics and proteomics and apply machine learning to identify biological and clinical signatures that drive cardiac function and outcomes in cardiomyopathy. Harmonized phenotyping and multiomics protocols across registries will create a uniquely integrated national data resource and enable the goals of AID-HF i.e., earlier diagnosis and new therapeutic targets for diastolic HF in cardiomyopathy.Keywords
Funding Information
- Canadian Institutes of Health Research (HFN 181992)
- Canadian Heart Function Alliance
- Bristol-Myers Squibb Canada
- Ted Rogers Centre For Heart Research
This publication has 27 references indexed in Scilit:
- Abnormal Lipid Signaling Characterizes Diastolic Dysfunction in Pediatric CardiomyopathyJACC: Basic To Translational Science, 2026
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography and for Heart Failure With Preserved Ejection Fraction Diagnosis: An Update From the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2025
- Genome-wide enhancer-associated tandem repeats are expanded in cardiomyopathyEBioMedicine, 2024
- Remodeling of lipid landscape in high fat fed very-long chain acyl-CoA dehydrogenase null mice favors pro-arrhythmic polyunsaturated fatty acids and their downstream metabolitesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- 2023 ACC Expert Consensus Decision Pathway on Management of Heart Failure With Preserved Ejection FractionJACC, 2023
- Pediatric Heart Network Echocardiographic Z Scores: Comparison with Other Published ModelsJournal of the American Society of Echocardiography, 2020
- The Hearts in Rhythm Organization: A Canadian National Cardiogenetics NetworkCJC Open, 2020
- Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2016
- RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathyHuman Genetics, 2007
- Diastolic heart failure and left ventricular diastolic dysfunction: What we know, and what we don't know!International Journal of Cardiology, 2007